The total number of prevalent cases of CKD across the countries under study will increase by 20% from 343 million in 2016 to 411 million in 2026. Of the 1.5 million people with stage 5 CKD,…
The total number of prevalent cases of CKD across the countries under study will increase by 24% from 17.8 million in 2016 to 22 million in 2026. Of the 153,000 people with stage 5 CKD,…
The total number of prevalent cases of CKD across the Asia-Pacific countries under study will increase by 25% from 51 million in 2016 to 64 million in 2026. Of the 460,000 people with stage 5…
The total number of prevalent cases of CKD across the European countries under study will increase by 11% from 14.4 million in 2016 to 16 million in 2026. Of the 191,000 people with stage 5 CKD…
The total number of prevalent cases of CKD across the countries under study will increase by 29% from 24 million in 2016 to 31 million in 2026. Of the 62.2 thousand people with stage 5 CKD,…
Parkinson’s disease (PD) treatment is complex; the disease is heterogeneous, requiring individualized treatment and frequent adjustments (e.g., in dosing, in regimens) to achieve symptom control…
Colorectal cancer is the third-most-common cancer globally and is associated with a five-year OS of Current treatment for metastatic colorectal cancer is dominated by chemotherapy regimens in…
The type 2 diabetes market has become increasingly crowded, with therapies competing over preferential formulary placement as well as patient share. Using primary research from U.S…
Diabetic macular edema (DME) associated with diabetic retinopathy (DR) is a rapidly evolving market as a result of multiple intravitreal pharmacotherapy product approvals across different drug…
Spinal muscular atrophy (SMA) is an autosomal recessive disease characterized by progressive muscle weakness due to the loss of anterior horn motor neurons. Nearly all cases of SMA are caused by…
Prostate cancer requires a multidisciplinary treatment approach that incorporates surgery, radiotherapy, hormonal therapy, chemotherapy, bone-metastases-targeted therapy, and, in the United States…
Methicillin-resistant Staphylococcus aureus (MRSA) is a clinically important gram-positive pathogen in both the hospital and outpatient treatment settings. The recent FDA approvals of tedizolid (…
Despite advances in treatment, rates of mortality and hospitalization for worsening heart failure remain high among CHF patients, and development of therapies with improved efficacy is one of the…
In an era when healthcare payers are demanding more value for the money they spend on health services and pharmaceuticals, managed care organizations increasingly have focused on meeting nationally…
Despite the recent launches of several new therapies, adding to the range of pharmacotherapies available for treating PAH, and contributing to the complexity of the PAH treatment algorithm, a…
